Organization
Novartis Institutes for Biomedical Research, Basel, Switzerland
1 abstract
Abstract
ANTI-IL-17A TREATMENT BLOCKS INFLAMMATION AND NEW BONE FORMATION IN EXPERIMENTAL SPONDYLOARTHRITIS IN HLA-B27 TRANSGENIC RATS Org: Clinical Immunology and Rheumatology/Experimental Immunology, Academic Medical Center, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, Novartis Institutes for Biomedical Research, Basel, Switzerland, Rheumatic Diseases Division, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States,